Johnson & Johnson (JNJ) Inventory (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Inventory came in at $14.6 billion in Q1 2026, up 15.2% year-on-year from $12.7 billion in Q1 2025, and up 2.76% quarter-over-quarter from $14.2 billion in Q4 2025.

Johnson & Johnson (JNJ) Inventory (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Inventory across 18 years of filings, most recently posting $14.6 billion for Q1 2026.

  • Inventory for Q1 2026 came in at $14.6 billion, up 15.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.6 billion (up 15.2% YoY), and the FY2025 annual result was $14.2 billion, up 14.04% from the prior year.
  • Inventory came in at $14.6 billion for Q1 2026 at Johnson & Johnson, up from $14.2 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $14.6 billion in Q1 2026 to a low of $10.3 billion in Q1 2023.
  • The 5-year median for Inventory is $12.3 billion (2024), against an average of $12.2 billion.
  • Across the five-year window, Inventory rose 16.55% in 2023 and declined 11.13% in 2024, its largest moves.
  • Johnson & Johnson's Inventory stood at $11.7 billion in 2022, then decreased by 4.23% to $11.2 billion in 2023, then grew by 11.3% to $12.4 billion in 2024, then rose by 14.04% to $14.2 billion in 2025, then advanced by 2.76% to $14.6 billion in 2026.
  • The last three Inventory figures came in at $14.6 billion (Q1 2026), $14.2 billion (Q4 2025), and $14.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 8.30 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 14.53 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 14.58 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 5.05 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 6.48 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 6.19 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 1.91 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 10.67 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 2.76 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 14.58 Bn
Dec 28, 2025 14.19 Bn
Sep 28, 2025 14.15 Bn
Jun 29, 2025 13.41 Bn
Mar 30, 2025 12.66 Bn
Dec 29, 2024 12.44 Bn
Sep 29, 2024 12.60 Bn
Jun 30, 2024 12.17 Bn
Mar 31, 2024 11.38 Bn
Dec 31, 2023 11.18 Bn
Oct 1, 2023 11.20 Bn
Jul 2, 2023 12.89 Bn
Apr 2, 2023 12.81 Bn
Jan 1, 2023 10.27 Bn
Oct 2, 2022 11.68 Bn
Jul 3, 2022 11.44 Bn
Apr 3, 2022 10.99 Bn
Jan 2, 2022 10.39 Bn
Oct 3, 2021 10.39 Bn
Jul 4, 2021 10.10 Bn